-
Je něco špatně v tomto záznamu ?
Low CD46 expression on activated CD4+ T cells predict improved Th1 cell reactivity to calcitriol in majority of patients with allergic eosinophilic asthma and healthy donors
J. Stichova, P. Slanina, Z. Chovancova, J. Baros, M. Litzman, J. Litzman, M. Vlkova
Status neindexováno Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2020
PubMed Central
od 2020
ROAD: Directory of Open Access Scholarly Resources
od 2020
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Previous research showed that the intracellular complement system, with CD46 as its central molecule, regulates the Th1 response associated with IFN-γ production and transition to a type 1 regulatory response (Tr1) characterized by IL-10 production. This transition can be influenced by a vitamin D (calcitriol), favouring a shift towards Tr1 cells and increased IL-10 production, as described in some autoimmune diseases. OBJECTIVE: It is unknown whether calcitriol modulates CD46-induced Th1 response towards regulatory type 1 T cells (Tr1) in allergic eosinophilic asthma and its value in relation to reducing inflammatory response. METHODS: CD4+ T cells from 58 patients with allergic eosinophilic asthma (AEA) and 49 healthy donors (HDs) were stimulated with αCD3/αCD46/IL-2 or αCD3/αCD46/IL-2/Calcitriol in vitro for 60 h and analyzed by flow cytometry. IFN-γ and IL-10 levels in cell culture supernatants were measured using ELISA. RESULTS: CD4+ T cells from patients with AEA demonstrated elevated CD46 expression in both the non-activated state and under stimulation conditions with αCD3/αCD46/IL-2 or αCD3/αCD46/IL-2/Calcitriol. Moreover, CD46 expression in AEA patients fluctuated with the pollen season, showing a significant increase during period of low pollen exposure. Calcitriol further induced CD4+Tr1 cells from in vitro generated CD4+Th1 cells in both HDs and AEA patients. However, in both cohorts were individuals (HDs: 35/49, AEA: 40/58) who responded to calcitriol with a more pronounced regulatory response. The calcitriol-induced regulatory effect manifested by a stronger surface decrease of CD46 on activated CD4+ T cells (by 40% in HDs and by 26% in AEA), accompanied by a significant inhibition of IFN-γ and increased IL-10 production (by 31% in HDs and by 85% in AEA). These individuals were termed as the CD46D group. Contrary to this, calcitriol induced an increase in CD46 expression at the CD4+ T cell surface in a minor group of HDs (14/49), and AEA patients (18/58), who were termed as the CD46I group. In CD46I group, CD4+ T cells produced less IFN-γ in comparison with CD46D group (by 33% in HDs and by 43% in AEA) and were unable to upregulate IL-10 production following stimulation with αCD3/αCD46/IL-2/Calcitriol. CONCLUSION: Our results suggest the potential existence of a key for stratifying individuals suitable for calcitriol treatment in the context of low serum vitamin D levels. After validation in clinical studies, this key could be used as an adjunctive therapy not only for patients with allergic eosinophilic asthma, but also for other diseases.
Department of Economics Faculty of Business and Economics Mendel University Brno Czechia
Faculty of Medicine Institute of Clinical Immunology and Allergology Masaryk University Brno Czechia
Institute of Clinical Immunology and Allergology St Anne's University Hospital Brno Czechia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25002473
- 003
- CZ-PrNML
- 005
- 20250428104131.0
- 007
- ta
- 008
- 250117e20240924sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/falgy.2024.1462579 $2 doi
- 035 __
- $a (PubMed)39403120
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Stichova, Julie $u Faculty of Medicine, Institute of Clinical Immunology and Allergology, Masaryk University, Brno, Czechia $u Institute of Clinical Immunology and Allergology, St. Anne's University Hospital, Brno, Czechia
- 245 10
- $a Low CD46 expression on activated CD4+ T cells predict improved Th1 cell reactivity to calcitriol in majority of patients with allergic eosinophilic asthma and healthy donors / $c J. Stichova, P. Slanina, Z. Chovancova, J. Baros, M. Litzman, J. Litzman, M. Vlkova
- 520 9_
- $a BACKGROUND: Previous research showed that the intracellular complement system, with CD46 as its central molecule, regulates the Th1 response associated with IFN-γ production and transition to a type 1 regulatory response (Tr1) characterized by IL-10 production. This transition can be influenced by a vitamin D (calcitriol), favouring a shift towards Tr1 cells and increased IL-10 production, as described in some autoimmune diseases. OBJECTIVE: It is unknown whether calcitriol modulates CD46-induced Th1 response towards regulatory type 1 T cells (Tr1) in allergic eosinophilic asthma and its value in relation to reducing inflammatory response. METHODS: CD4+ T cells from 58 patients with allergic eosinophilic asthma (AEA) and 49 healthy donors (HDs) were stimulated with αCD3/αCD46/IL-2 or αCD3/αCD46/IL-2/Calcitriol in vitro for 60 h and analyzed by flow cytometry. IFN-γ and IL-10 levels in cell culture supernatants were measured using ELISA. RESULTS: CD4+ T cells from patients with AEA demonstrated elevated CD46 expression in both the non-activated state and under stimulation conditions with αCD3/αCD46/IL-2 or αCD3/αCD46/IL-2/Calcitriol. Moreover, CD46 expression in AEA patients fluctuated with the pollen season, showing a significant increase during period of low pollen exposure. Calcitriol further induced CD4+Tr1 cells from in vitro generated CD4+Th1 cells in both HDs and AEA patients. However, in both cohorts were individuals (HDs: 35/49, AEA: 40/58) who responded to calcitriol with a more pronounced regulatory response. The calcitriol-induced regulatory effect manifested by a stronger surface decrease of CD46 on activated CD4+ T cells (by 40% in HDs and by 26% in AEA), accompanied by a significant inhibition of IFN-γ and increased IL-10 production (by 31% in HDs and by 85% in AEA). These individuals were termed as the CD46D group. Contrary to this, calcitriol induced an increase in CD46 expression at the CD4+ T cell surface in a minor group of HDs (14/49), and AEA patients (18/58), who were termed as the CD46I group. In CD46I group, CD4+ T cells produced less IFN-γ in comparison with CD46D group (by 33% in HDs and by 43% in AEA) and were unable to upregulate IL-10 production following stimulation with αCD3/αCD46/IL-2/Calcitriol. CONCLUSION: Our results suggest the potential existence of a key for stratifying individuals suitable for calcitriol treatment in the context of low serum vitamin D levels. After validation in clinical studies, this key could be used as an adjunctive therapy not only for patients with allergic eosinophilic asthma, but also for other diseases.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Slanina, Peter $u Faculty of Medicine, Institute of Clinical Immunology and Allergology, Masaryk University, Brno, Czechia $u Institute of Clinical Immunology and Allergology, St. Anne's University Hospital, Brno, Czechia $7 xx0331796
- 700 1_
- $a Chovancova, Zita $u Faculty of Medicine, Institute of Clinical Immunology and Allergology, Masaryk University, Brno, Czechia $u Institute of Clinical Immunology and Allergology, St. Anne's University Hospital, Brno, Czechia
- 700 1_
- $a Baros, Jan $u Faculty of Medicine, Institute of Clinical Immunology and Allergology, Masaryk University, Brno, Czechia $u Institute of Clinical Immunology and Allergology, St. Anne's University Hospital, Brno, Czechia
- 700 1_
- $a Litzman, Marek $u Department of Economics, Faculty of Business and Economics, Mendel University, Brno, Czechia
- 700 1_
- $a Litzman, Jiri $u Faculty of Medicine, Institute of Clinical Immunology and Allergology, Masaryk University, Brno, Czechia $u Institute of Clinical Immunology and Allergology, St. Anne's University Hospital, Brno, Czechia
- 700 1_
- $a Vlkova, Marcela $u Faculty of Medicine, Institute of Clinical Immunology and Allergology, Masaryk University, Brno, Czechia $u Institute of Clinical Immunology and Allergology, St. Anne's University Hospital, Brno, Czechia
- 773 0_
- $w MED00209375 $t Frontiers in allergy $x 2673-6101 $g Roč. 5 (20240924), s. 1462579
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39403120 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250117 $b ABA008
- 991 __
- $a 20250428104129 $b ABA008
- 999 __
- $a ok $b bmc $g 2254593 $s 1238476
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2024 $b 5 $c - $d 1462579 $e 20240924 $i 2673-6101 $m Frontiers in allergy $n Front Allergy $x MED00209375
- LZP __
- $a Pubmed-20250117